Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial.
Ravaud A, Trufflandier N, Ferrière JM, Debled M, Palussière J, Cany L, Gaston R, Mathoulin-Pélissier S, Bui BN. Ravaud A, et al. Among authors: bui bn. Br J Cancer. 2003 Dec 15;89(12):2213-8. doi: 10.1038/sj.bjc.6601419. Br J Cancer. 2003. PMID: 14676797 Free PMC article. Clinical Trial.
[Adverse effects of interleukin 2].
Ravaud A, Negrier S, Lakdja F, Mercatello A, Cany L, Coronel B, Ranchere JY, Bécouarn Y, Bui BN, Philip T. Ravaud A, et al. Among authors: bui bn. Bull Cancer. 1991 Nov;78(11):989-1005. Bull Cancer. 1991. PMID: 1369555 Review. French.
Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
Ravaud A, Chevreau C, Cany L, Houyau P, Dohollou N, Roché H, Soubeyran P, Bonichon F, Mihura J, Eghbali H, Tabah I, Bui BN. Ravaud A, et al. Among authors: bui bn. J Clin Oncol. 1998 Sep;16(9):2930-6. doi: 10.1200/JCO.1998.16.9.2930. J Clin Oncol. 1998. PMID: 9738560 Clinical Trial.
Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study.
Penel N, Glabbeke MV, Mathoulin-Pelissier S, Judson I, Sleijfer S, Bui B, Schoffski P, Ouali M, Marreaud S, Brouste V, Duhamel A, Hohenberger P, Blay JY. Penel N, et al. Br J Cancer. 2011 May 10;104(10):1544-50. doi: 10.1038/bjc.2011.136. Epub 2011 Apr 19. Br J Cancer. 2011. PMID: 21505457 Free PMC article.
Brief report: Advanced paraganglioma: A role for chemotherapy?
Fitoussi O, Debled M, Masson B, Coindre JM, Kantor G, Bui BN. Fitoussi O, et al. Among authors: bui bn. Med Pediatr Oncol. 1999 Aug;33(2):129-31. doi: 10.1002/(sici)1096-911x(199908)33:2<129::aid-mpo15>3.0.co;2-x. Med Pediatr Oncol. 1999. PMID: 10398192 No abstract available.
104 results